| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new era of treatment for chronic lymphocytic leukaemia?
|
Brown, Jennifer R
|
|
2014
|
15 |
1 |
p. 3-5
3 p.
|
artikel
|
| 2 |
A new regimen for Burkitt's lymphoma
|
Burki, Talha Khan
|
|
2014
|
15 |
1 |
p. e5-
1 p.
|
artikel
|
| 3 |
A new start for global cancer care
|
Burki, Talha Khan
|
|
2014
|
15 |
1 |
p. 17-
1 p.
|
artikel
|
| 4 |
Anti-PD1 antibody: a new approach to treatment of lymphomas
|
Bachy, Emmanuel
|
|
2014
|
15 |
1 |
p. 7-8
2 p.
|
artikel
|
| 5 |
Art therapy: a year in pictures
|
Brierley, Rob
|
|
2014
|
15 |
1 |
p. 20-21
2 p.
|
artikel
|
| 6 |
Biomarkers for immune checkpoint inhibitors
|
Lievense, Lysanne A
|
|
2014
|
15 |
1 |
p. e1-
1 p.
|
artikel
|
| 7 |
Biomarkers for immune checkpoint inhibitors – Authors' reply
|
Calabrò, Luana
|
|
2014
|
15 |
1 |
p. e1-e2
nvt p.
|
artikel
|
| 8 |
Black-box warning: direct-to-consumer marketing
|
The Lancet Oncology,
|
|
2014
|
15 |
1 |
p. 1-
1 p.
|
artikel
|
| 9 |
Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study
|
De Angelis, Roberta
|
|
2014
|
15 |
1 |
p. 23-34
12 p.
|
artikel
|
| 10 |
Chemotherapy for small-cell lung cancer
|
Kalemkerian, Gregory P
|
|
2014
|
15 |
1 |
p. 13-14
2 p.
|
artikel
|
| 11 |
Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study
|
Gatta, Gemma
|
|
2014
|
15 |
1 |
p. 35-47
13 p.
|
artikel
|
| 12 |
Correction to Lancet Oncol 2013; 14: 1330, 1333, 1335
|
|
|
2014
|
15 |
1 |
p. e4-
1 p.
|
artikel
|
| 13 |
Correction to Lancet Oncol 2013; 14: 1279, 1283, 1285
|
|
|
2014
|
15 |
1 |
p. e4-
1 p.
|
artikel
|
| 14 |
Correction to Lancet Oncol 2013; 14: 1295–306
|
|
|
2014
|
15 |
1 |
p. e4-
1 p.
|
artikel
|
| 15 |
Cough-awareness campaign increases lung cancer diagnoses
|
Mayor, Susan
|
|
2014
|
15 |
1 |
p. e7-
1 p.
|
artikel
|
| 16 |
Dasatinib as first-line therapy for CML-CP
|
Gilbert, Judith A
|
|
2014
|
15 |
1 |
p. e7-
1 p.
|
artikel
|
| 17 |
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
|
Ford, Hugo E R
|
|
2014
|
15 |
1 |
p. 78-86
9 p.
|
artikel
|
| 18 |
Effects of histone deacetylase inhibitors on alloresponses
|
Hancock, Wayne W
|
|
2014
|
15 |
1 |
p. 10-11
2 p.
|
artikel
|
| 19 |
Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study
|
Kubota, Kaoru
|
|
2014
|
15 |
1 |
p. 106-113
8 p.
|
artikel
|
| 20 |
Evidence-based treatment for low-risk basal cell carcinoma
|
Lear, John T
|
|
2014
|
15 |
1 |
p. 12-13
2 p.
|
artikel
|
| 21 |
Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial
|
O'Brien, Susan
|
|
2014
|
15 |
1 |
p. 48-58
11 p.
|
artikel
|
| 22 |
Immunotherapy in non-small-cell lung cancer: a good start?
|
Bogart, Jeffrey A
|
|
2014
|
15 |
1 |
p. 5-6
2 p.
|
artikel
|
| 23 |
Interpretation of EUROCARE-5
|
Munro, Alastair J
|
|
2014
|
15 |
1 |
p. 2-3
2 p.
|
artikel
|
| 24 |
Major breast cancer trial gives high marks to anastrozole
|
Maurice, John
|
|
2014
|
15 |
1 |
p. e6-
1 p.
|
artikel
|
| 25 |
Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial
|
Barrett-Lee, Peter
|
|
2014
|
15 |
1 |
p. 114-122
9 p.
|
artikel
|
| 26 |
Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint
|
Hellmann, Matthew D
|
|
2014
|
15 |
1 |
p. e42-e50
nvt p.
|
artikel
|
| 27 |
Rechallenge with imatinib in GIST: is more always RIGHT?
|
Urban, Damien
|
|
2014
|
15 |
1 |
p. e2-e3
nvt p.
|
artikel
|
| 28 |
Recommendations for management of patients with neuroendocrine liver metastases
|
Frilling, Andrea
|
|
2014
|
15 |
1 |
p. e8-e21
nvt p.
|
artikel
|
| 29 |
Revelling in the ordinary
|
Sekkides, Onisillos
|
|
2014
|
15 |
1 |
p. 20-
1 p.
|
artikel
|
| 30 |
Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial
|
Westin, Jason R
|
|
2014
|
15 |
1 |
p. 69-77
9 p.
|
artikel
|
| 31 |
Second-line chemotherapy for patients with oesophagogastric adenocarcinoma
|
Park, Se Hoon
|
|
2014
|
15 |
1 |
p. 8-10
3 p.
|
artikel
|
| 32 |
Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial
|
Bath-Hextall, Fiona
|
|
2014
|
15 |
1 |
p. 96-105
10 p.
|
artikel
|
| 33 |
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
|
Butts, Charles
|
|
2014
|
15 |
1 |
p. 59-68
10 p.
|
artikel
|
| 34 |
Testosterone can boost sexual function after hysterectomy
|
Tanday, Sanjay
|
|
2014
|
15 |
1 |
p. e6-
1 p.
|
artikel
|
| 35 |
55th ASH Annual Meeting
|
Fricker, Janet
|
|
2014
|
15 |
1 |
p. 18-
1 p.
|
artikel
|
| 36 |
The language of cancer
|
Burki, Talha Khan
|
|
2014
|
15 |
1 |
p. 21-22
2 p.
|
artikel
|
| 37 |
The Peloton Project
|
Smith, Lan-Lan
|
|
2014
|
15 |
1 |
p. 19-
1 p.
|
artikel
|
| 38 |
The scope of nanoparticle therapies for future metastatic melanoma treatment
|
Bombelli, Francesca Baldelli
|
|
2014
|
15 |
1 |
p. e22-e32
nvt p.
|
artikel
|
| 39 |
Times Like These: men with breast cancer
|
Towey, Francesca
|
|
2014
|
15 |
1 |
p. 22-
1 p.
|
artikel
|
| 40 |
Tumour growth in stressed mice
|
Burki, Talha Khan
|
|
2014
|
15 |
1 |
p. e5-
1 p.
|
artikel
|
| 41 |
Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review
|
Kumar, Naresh
|
|
2014
|
15 |
1 |
p. e33-e41
nvt p.
|
artikel
|
| 42 |
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial
|
Choi, Sung Won
|
|
2014
|
15 |
1 |
p. 87-95
9 p.
|
artikel
|
| 43 |
Which bisphosphonate to treat bone metastases?
|
Costa, Luis
|
|
2014
|
15 |
1 |
p. 15-16
2 p.
|
artikel
|
Tijdschrift beschrijving